![]() |
Name |
Botryosulfuranol C
|
Molecular Formula | C19H16N2O6S2 | |
IUPAC Name* |
(1R,9S,12R,13R,14R)-13-hydroxy-18-methylspiro[2,15-dioxa-10,11-dithia-16,18-diazapentacyclo[10.5.2.01,9.03,8.012,16]nonadeca-3,5,7-triene-14,6'-cyclohex-2-ene]-1',17,19-trione
|
|
SMILES |
CN1C(=O)[C@]23[C@@H]([C@@]4(CCC=CC4=O)ON2C(=O)[C@@]15[C@H](C6=CC=CC=C6O5)SS3)O
|
|
InChI |
InChI=1S/C19H16N2O6S2/c1-20-16(25)19-14(23)17(9-5-4-8-12(17)22)27-21(19)15(24)18(20)13(28-29-19)10-6-2-3-7-11(10)26-18/h2-4,6-8,13-14,23H,5,9H2,1H3/t13-,14+,17-,18-,19+/m0/s1
|
|
InChIKey |
VOUCYTUBFKLYLN-AQQQZIQISA-N
|
|
Synonyms |
Botryosulfuranol C
|
|
CAS | NA | |
PubChem CID | 146682375 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 432.5 | ALogp: | 0.5 |
HBD: | 1 | HBA: | 8 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 147.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 29 | QED Weighted: | 0.618 |
Caco-2 Permeability: | -5.035 | MDCK Permeability: | 0.00002020 |
Pgp-inhibitor: | 0.382 | Pgp-substrate: | 0.029 |
Human Intestinal Absorption (HIA): | 0.222 | 20% Bioavailability (F20%): | 0.726 |
30% Bioavailability (F30%): | 0.9 |
Blood-Brain-Barrier Penetration (BBB): | 0.852 | Plasma Protein Binding (PPB): | 60.45% |
Volume Distribution (VD): | 1.281 | Fu: | 46.15% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.826 |
CYP2C19-inhibitor: | 0.419 | CYP2C19-substrate: | 0.908 |
CYP2C9-inhibitor: | 0.787 | CYP2C9-substrate: | 0.261 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.11 |
CYP3A4-inhibitor: | 0.363 | CYP3A4-substrate: | 0.938 |
Clearance (CL): | 9.257 | Half-life (T1/2): | 0.713 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.161 |
Drug-inuced Liver Injury (DILI): | 0.982 | AMES Toxicity: | 0.879 |
Rat Oral Acute Toxicity: | 0.997 | Maximum Recommended Daily Dose: | 0.468 |
Skin Sensitization: | 0.91 | Carcinogencity: | 0.936 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.754 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004039 | ![]() |
0.663 | D00JRA | ![]() |
0.261 | ||
ENC004040 | ![]() |
0.487 | D08UMH | ![]() |
0.248 | ||
ENC003544 | ![]() |
0.354 | D08EOD | ![]() |
0.242 | ||
ENC003545 | ![]() |
0.354 | D05MQK | ![]() |
0.239 | ||
ENC003540 | ![]() |
0.336 | D06BYV | ![]() |
0.235 | ||
ENC003747 | ![]() |
0.327 | D0E3WQ | ![]() |
0.229 | ||
ENC003549 | ![]() |
0.306 | D0U7GK | ![]() |
0.227 | ||
ENC003992 | ![]() |
0.304 | D08CCE | ![]() |
0.224 | ||
ENC003438 | ![]() |
0.300 | D07RGW | ![]() |
0.223 | ||
ENC002358 | ![]() |
0.299 | D0Z9NZ | ![]() |
0.221 |